title: Lipoprotein(a) and its position among other risk factors of atherosclerosis.
abstract: Lipoprotein(a) [Lp(a)] comprises of an LDL particle and apolipoprotein(a) [apo(a)] and its elevated levels are considered a risk factor for atherosclerosis. The aim of our study was to find out whether elevated Lp(a) levels are associated with increased risk of atherosclerosis in patients with multiple other risk factors. We further tested the association of three polymorphisms of the apo(a) gene promoter with Lp(a) levels. No significant correlation was detected between Lp(a) levels and lipid and clinical parameters tested. The study demonstrated a significantly (p=0.0219) elevated Lp(a) level (mean 28+/-35 mg/dl, median 0.14) in patients with coronary heart disease (CHD). In a group with premature CHD the correlation was not significant anymore. There was a significant correlation between polymorphic loci of the promoter region of apo(a) gene and Lp(a) levels (+93C T, p=0.0166, STR, p<0.0001). Our study suggests that elevated Lp(a) level is an independent risk factor of CHD in carriers of other important CHD risk factors. Observed association of sequence variants of the promoter of apo(a) gene with Lp(a) levels is caused in part due to linkage to a restricted range of apo(a) gene length isoforms.
authors.affiliation: Third Medical Department, First Faculty of Medicine and General Teaching Hospital, Charles University, Prague, Czech Republic. l.zlato@tiscali.cz
authors.forename: L
authors.initials: L
authors.lastname: Zlatohlávek
authors.forename: K
authors.initials: K
authors.lastname: Zídková
authors.forename: M
authors.initials: M
authors.lastname: Vrablík
authors.forename: T
authors.initials: T
authors.lastname: Haas
authors.forename: M
authors.initials: M
authors.lastname: Prusíková
authors.forename: H
authors.initials: H
authors.lastname: Svobodová
authors.forename: R
authors.initials: R
authors.lastname: Ceska
mesh_terms: D000328:Adult; D000368:Aged; D053241:Apoprotein(a) / Q000097:blood / Q000235:genetics; D015415:Biomarkers / Q000097:blood; D003324:Coronary Artery Disease / Q000209:etiology* / Q000235:genetics / Q000378:metabolism; D003327:Coronary Disease / Q000209:etiology* / Q000235:genetics / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D008055:Lipids / Q000097:blood; D017270:Lipoprotein(a) / Q000097:blood* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D050177:Overweight / Q000150:complications; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic; D018570:Risk Assessment; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D015854:Up-Regulation
chemical_list: D015415:Biomarkers; D008055:Lipids; D017270:Lipoprotein(a); D053241:Apoprotein(a)